Tepmetko (Tepotinib)
- Medicine Name: Tepmetko
- Generic Name: Tepotinib
- Dosage Form & Strength: Tablets: 225 mg
- Manufactured By: EMD Serono, Inc.
Medical Uses
Tepmetko is a kinase inhibitor used for the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) harboring mesenchymal-epithelial transition (MET) exon 14 skipping alterations.
Recommended Dosage: The recommended dosage is 450 mg orally once daily with food until disease progression or unacceptable toxicity.Dose of Tepmetko tablet is taken at approximately the fixed time every day. Swallow the tablets whole. Do not chew, crush or split tablets. Do not to make up a missed dose within 8 hours of the next scheduled dose. In case vomiting occurs after taking a dose, patients should take the next dose at the scheduled time.
Warning & Precautions
- ILD/pneumonitis, which can be fatal, occurred in patients treated with Tepmetko 225 mg tabets. Assess patients for new or worsening pulmonary signs/symptoms indicative of ILD/pneumonitis (e.g., cough, dyspnea, fever).
- Hepatotoxicity occurred in patients treated with Tepotinib. Monitor liver function tests (including AST, ALT, and total bilirubin) prior to the start of Tepotinib, every 2 weeks during the initial three months of treatment, then monthly, with a bit more frequent testing in those who develop enhanced transaminases or bilirubin.
- Depending on findings and its mechanism of action Tepmetko 225 mg can cause fetal harm if used by a pregnant woman. Females of reproductive age or males with female partners of reproductive age should use apt contraception during treatment and for 1-week after the last dose.
- Breastfeeding is restricted in women’s taking treatment with Tepotinib 225 mg. Women should not breastfeed during treatment and for 1-week after the last dose.
- Respective patients should inform their health specialist of all concomitant medicines, including prescription medications, over-the-counter drugs and herbal products.
Documentation & Availability
What documents are required to import TEPMETKO to India?
TEPMETKO (tepotinib) tablets can be imported by patients or government hospitals on the name of the patients only.
The following documentation are needed to import the product:
- A valid prescription from a qualified doctor.
- Patient’s diagnostic reports.
- Patient’s ID proof (issued by the Government of India).
How is the order confirmed?
The order will be confirmed only after the receipt of:
- A valid prescription from a doctor.
- Import permit if applicable.
Is TEPMETKO available in India?
TEPMETKO (tepotinib tablets) is a (prescription drug, prescription medication or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.
S S Healthcare (S S Healthcare) helps import cancer medicines on the named patient supply (NPS). S S Healthcare is facilitator providing input
- On availability of Tepmetko in India (Hyderabad, Mumbai, Kolkata, Chennai, Ahmedabad, Delhi, Bangalore and Pune etc.)
- Medicine Price.
- Finding Genuine and reliable source from Canada, Europe, USA and Australia
- Ensuring 100% transparency.
TEPMETKO can be made available to patients, doctors and hospitals at Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow and Pune and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and import permit.
S S Healthcare (S S Healthcare) can facilitate the supply of TEPMETKO (prescription medicines) to all locations in the world and in India after fulfilling the legal requirement (if applicable)
Please contact +91-7575883015 | Toll-Free No: +91-7575883015 or write us at sshealthcare1012@gmail.com for Tepmetko tablets price in India.
We take guarantee of quality and delivery anywhere in the world as per the buyer’s requirements.
Sourcing & Delivery
S S Healthcare is able to source TEPMETKO (Cancer Treatment Medicines) from across the globe, and has the ability to supply. S S Healthcare offers its customers worldwide access to the best available treatment.
S S Healthcare is able to dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient’s address only from New Delhi, India.
FAQ
What is the Generic Name for the trade name drug Tepmetko®?
Tepotinib is Generic Name for the trade name drug Tepmetko®.
Is Tepmetko® approved by the FDA?
Yes, Tepmetko® is approved by the FDA. Date of approval: February 3, 2021.
How is Tepmetko® typically administered?
Tepmetko (Tepotinib Tablets) taken once daily with food. The tablet should be swallowed completely and never broken, opened, or chewed. Discuss with your health specialist for instructions in case you vomit or miss any dose.
What is the dosage and form of Tepmetko® supplied?
Tepmetko® is supplied as Tablets: 225 mg dosage strength for oral administration.
What are the most common side effects due to Tepmetko®?
Most common side effects due to Tepmetko® include: nausea, edema, fatigue, diarrhea, musculoskeletal pain, and dyspnea.
How much does Tepmetko® cost in India?
Tepmetko cost in India is sensibly reasonable. In order to procure this NSCLC medication authentically, you can call or WhatsApp +91-7575883015 or send mail to sshealthcare1012@gmail.com.
What are the storage conditions of Tepmetko®?
Store the tablets at temperature 20°C to 25°C (68°F to 77°F); excursions permitted to 15°C to 30°C (59°F to 86°F). Store in the original package.
Is it safe to buy Tepmetko® online in India?
Yes, In order to buy Tepotinib in India, always choose an absolutely legitimate, and WHO-GDP & ISO certified Pharmaceutical Wholesaler/Distributor/Supplier.
What are the Highlights of prescribing information for Tepmetko®?
Click Here to download full Tepmetko prescribing information.
Contact Patient Support
If you have any questions or need any help, contact our Patient Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
Email Address
Sshealthcare1012@gmail.com
+91 7575883015
Landline
079 48916267
Disclaimer
All Trademarks and Brands that appear on the website belong to their respective owners, and S S Healthcare does not lay any claim on them. We only provide information.
